XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.25.1

OPERATING SEGMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
OPERATING SEGMENTS |
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2024 net sales and operating income | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2024
​ |  | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
​ | ​ | 2024 Reported | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Fixed | ​ | ​ | ​ | 2024 Reported
​ | ​ | Valued at 2024 |  | ​ | ​ |  | Currency | ​ |  | Valued at 2025
(millions) | ​ | Management Rates |  | Other | ​ |  | Rate Change | ​ |  | Management Rates
Net Sales | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Global Water | ​ | ​ | $7,857.2 | ​ | ​ | ​ | ($1.2) | ​ | ​ | ​ | ​ | ($372.6) | ​ | ​ | ​ | ​ | $7,483.4 | ​
Global Institutional & Specialty | ​ | ​ | 5,413.9 | ​ | ​ | ​ | 726.0 | ​ | ​ | ​ | ​ | (160.5) | ​ | ​ | ​ | ​ | 5,979.4 | ​
Global Pest Elimination | ​ | ​ | 1,167.8 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (27.7) | ​ | ​ | ​ | ​ | 1,140.1 | ​
Global Life Sciences | ​ | ​ | 1,434.1 | ​ | ​ | ​ | (724.8) | ​ | ​ | ​ | ​ | (38.8) | ​ | ​ | ​ | ​ | 670.5 | ​
Subtotal at fixed currency rates | ​ | ​ | 15,873.0 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (599.6) | ​ | ​ | ​ | ​ | 15,273.4 | ​
Effect of foreign currency translation | ​ | ​ | (131.6) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 599.6 | ​ | ​ | ​ | ​ | 468.0 | ​
Consolidated reported GAAP net sales | ​ | ​ | $15,741.4 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $15,741.4 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cost of Sales | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Global Water | ​ | ​ | $4,691.2 | ​ | ​ | ​ | $2.0 | ​ | ​ | ​ | ​ | ($222.3) | ​ | ​ | ​ | ​ | $4,470.9 | ​
Global Institutional & Specialty | ​ | ​ | 2,727.5 | ​ | ​ | ​ | 490.6 | ​ | ​ | ​ | ​ | (87.1) | ​ | ​ | ​ | ​ | 3,131.0 | ​
Global Pest Elimination | ​ | ​ | 655.0 | ​ | ​ | ​ | 0.1 | ​ | ​ | ​ | ​ | (15.3) | ​ | ​ | ​ | ​ | 639.8 | ​
Global Life Sciences | ​ | ​ | 895.1 | ​ | ​ | ​ | (492.7) | ​ | ​ | ​ | ​ | (19.8) | ​ | ​ | ​ | ​ | 382.6 | ​
Corporate | ​ | ​ | 5.4 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (0.2) | ​ | ​ | ​ | ​ | 5.2 | ​
Subtotal at fixed currency rates | ​ | ​ | $8,974.2 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | ($344.7) | ​ | ​ | ​ | ​ | $8,629.5 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Selling, General and Administrative Expenses | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Global Water | ​ | ​ | $1,865.4 | ​ | ​ | ​ | $3.1 | ​ | ​ | ​ | ​ | ($63.2) | ​ | ​ | ​ | ​ | $1,805.3 | ​
Global Institutional & Specialty | ​ | ​ | 1,503.7 | ​ | ​ | ​ | 181.2 | ​ | ​ | ​ | ​ | (38.7) | ​ | ​ | ​ | ​ | 1,646.2 | ​
Global Pest Elimination | ​ | ​ | 292.4 | ​ | ​ | ​ | 5.1 | ​ | ​ | ​ | ​ | (6.9) | ​ | ​ | ​ | ​ | 290.6 | ​
Global Life Sciences | ​ | ​ | 391.8 | ​ | ​ | ​ | (189.4) | ​ | ​ | ​ | ​ | (6.3) | ​ | ​ | ​ | ​ | 196.1 | ​
Corporate | ​ | ​ | 199.3 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (3.7) | ​ | ​ | ​ | ​ | 195.6 | ​
Subtotal at fixed currency rates | ​ | ​ | $4,252.6 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | ($118.8) | ​ | ​ | ​ | ​ | $4,133.8 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Special (Gains) and Charges | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​
Corporate | ​ | ​ | (188.9) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 0.2 | ​ | ​ | ​ | ​ | (188.7) | ​
Subtotal at fixed currency rates | ​ | ​ | ($188.9) | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $0.2 | ​ | ​ | ​ | ​ | ($188.7) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Water | ​ | ​ | $1,300.6 | ​ | ​ | ​ | ($6.3) | ​ | ​ | ​ | ​ | ($87.1) | ​ | ​ | ​ | ​ | $1,207.2 | ​
Global Institutional & Specialty | ​ | ​ | 1,182.7 | ​ | ​ | ​ | 54.2 | ​ | ​ | ​ | ​ | (34.7) | ​ | ​ | ​ | ​ | 1,202.2 | ​
Global Pest Elimination | ​ | ​ | 220.4 | ​ | ​ | ​ | (5.2) | ​ | ​ | ​ | ​ | (5.5) | ​ | ​ | ​ | ​ | 209.7 | ​
Global Life Sciences | ​ | ​ | 147.2 | ​ | ​ | ​ | (42.7) | ​ | ​ | ​ | ​ | (12.7) | ​ | ​ | ​ | ​ | 91.8 | ​
Corporate | ​ | ​ | (15.8) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 3.7 | ​ | ​ | ​ | ​ | (12.1) | ​
Subtotal at fixed currency rates | ​ | ​ | 2,835.1 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (136.3) | ​ | ​ | ​ | ​ | 2,698.8 | ​
Effect of foreign currency translation | ​ | ​ | (32.7) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 136.3 | ​ | ​ | ​ | ​ | 103.6 | ​
Consolidated reported GAAP operating income | ​ | ​ | $2,802.4 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $2,802.4 | ​
Schedule of reportable segment information | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, 2025
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(millions) | ​ | Net Sales | ​ | COS | ​ | SG&A | ​ | Special (gains) and charges | ​ | Operating Income (Loss)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Water | ​ | $1,800.5 | ​ | $1,073.6 | ​ | $466.9 | ​ | $- | ​ | $260.0
Global Institutional & Specialty | ​ | 1,406.5 | ​ | 705.3 | ​ | 402.6 | ​ | - | ​ | 298.6
Global Pest Elimination | ​ | 278.1 | ​ | 161.7 | ​ | 70.3 | ​ | - | ​ | 46.1
Global Life Sciences | ​ | 167.0 | ​ | 90.4 | ​ | 51.4 | ​ | - | ​ | 25.2
Corporate | ​ | - | ​ | 4.7 | ​ | 48.5 | ​ | 29.3 | ​ | (82.5)
Subtotal at fixed currency rates | ​ | $3,652.1 | ​ | $2,035.7 | ​ | $1,039.7 | ​ | $29.3 | ​ | $547.4
Effect of foreign currency translation | ​ | 42.9 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 7.9
Consolidated reported GAAP | ​ | $3,695.0 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $555.3
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, 2024
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(millions) | ​ | Net Sales | ​ | COS | ​ | SG&A | ​ | Special (gains) and charges | ​ | Operating Income (Loss)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Water | ​ | $1,755.0 | ​ | $1,050.5 | ​ | $460.9 | ​ | $- | ​ | $243.6
Global Institutional & Specialty | ​ | 1,446.9 | ​ | 770.6 | ​ | 418.9 | ​ | - | ​ | 257.4
Global Pest Elimination | ​ | 260.3 | ​ | 147.5 | ​ | 66.3 | ​ | - | ​ | 46.5
Global Life Sciences | ​ | 159.3 | ​ | 84.6 | ​ | 55.4 | ​ | - | ​ | 19.3
Corporate | ​ | - | ​ | 1.6 | ​ | 48.9 | ​ | 28.3 | ​ | (78.8)
Subtotal at fixed currency rates | ​ | $3,621.5 | ​ | $2,054.8 | ​ | $1,050.4 | ​ | $28.3 | ​ | $488.0
Effect of foreign currency translation | ​ | 130.4 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 29.9
Consolidated reported GAAP | ​ | $3,751.9 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $517.9

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment, including disclosure of changes for comparability of reportable segments. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References No definition available. + Details
Name: | ecl_ScheduleOfSegmentReportingInformationBySegmentIncludingChangesForComparabilityOfReportableSegmentsTableTextBlock
Namespace Prefix: | ecl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration